Neil Woodford

A chink in the armour?

Neil Woodford's record-breaking Patient Capital investment trust moved to a premium shortly after launching on the London Stock Exchange.

Neil Woodford's Patient Capital trust has raised £800m during its offer period, a record for a London-listed investment trust.

Woodford Investment Management (WIM) has increased the initial fundraising limit for its Patient Capital trust from £500m to £800m in response to investor demand.

Neil Woodford has said next month's general election could mark the beginning of years of uncertainty for UK investors.

The Woodford effect

As Woodford Investment Management gears up for the launch of its Patient Capital investment trust, Investment Week visited the company's Oxford offices to quiz senior personnel about their plans for the future.

Woodford Investment Management (WIM) is to take a 15% performance fee of any excess returns above the 10% annual return target on its Patient Capital investment trust.

Fidelity FundsNetwork is to make Neil Woodford's Patient Capital trust the first externally-managed IT available on the platform, in what it says is a "clear intention" of more to come.

News of Neil Woodford's forthcoming trust investing in early stage companies has prompted comparisons with venture capital trusts (VCTs), but analysts say they are unlikely to appeal to the same kinds of investors.